One Strain, Millions in Value: China's Biomanufacturing's Most Precious "Seed"

A microbial strain sold for 1000 million yuan.

Recently, a news story has stirred significant excitement in the bio-manufacturing and agrochemical sectors—Sichuan Agricultural University exclusively licensed a patented strain to Nanjing Red Sun Shares for 1000 million yuan., officially named "Red Sun Subspecies".

In the biomanufacturing sector, technology transfer deals worth tens of millions are not unprecedented. Yet, it's remarkable that a single microbial strain commands such a high valuation:Why is this strain worth 1000 million? What industry logic does it reflect?

The technical "value" behind [ 1000 ] ten thousand yuan.

The lethal power of a single bacterial strain

This transaction involvesPatented Strain HS18-1It is not a fleeting "paper strain" confined to the lab. It is a mature engineered strain developed over many years by Professor Zheng Aiping's team at Sichuan Agricultural University, belonging to Bacillus thuringiensis—a prestigious family of bacteria in the biopesticide industry.

HS18-1Broad-spectrum insecticidal activityEffectively controls major agricultural pests, including Lepidoptera, aphids, and mites. Overcomes chemical pesticide resistance with high efficacy against key pests such as the rice stem borer, corn borer, fall armyworm, and cotton bollworm.

Furthermore, the commercialization pathway for this strain does not involve simple spray application of the bacterial culture. Instead, it extracts the peptide proteins produced by the strain as the active ingredient in pesticides. This approach ensures high insecticidal efficacy while offering significantly better ecological safety compared to chemical pesticides.

TRL 8: Bridging the "last mile" from lab to factory

It's not just the spectrum of efficacy that matters. The most critical value anchor behind the 1000 million price tag is...HS18-1 Technology Readiness Level (TRL) — 8 or higher。

The TRL framework consists of 9 levels, providing a systematic approach to assess a technology's progression from basic principles to mature application. TRL 8 signifies that the final design is complete, the product has passed all development testing and evaluation, and it is ready for small-batch production—enabling enterprises to confidently advance subsequent capacity building.

Based on the Red Sun's implementation plan,This strain will establish an intelligent fermentation production line with an annual capacity of 2 million tons within 3 years., the first "insecticidal protein pesticide"Expected to obtain pesticide registration and launch in 2027.After the project reaches full production capacity, the estimated annual sales revenue will be8 hundred million yuanand drive the development of supporting industries, with an estimated additional associated output value50 billion yuan or more。

The 1000 yuan transfer fee is merely a tiny footnote in the complete commercial value chain of this fungus.

Behind the Deal: Red Sun's Strategic Positioning

Red Sun, once a pesticide empire built by Yang Shouhai, former richest man in Nanjing. Founded in 1989, it started as a small pesticide packaging plant and grew over 30 years into a leading global top-five eco-friendly pesticide company. However, Red Sun underwent a dramatic bankruptcy reorganization starting in 2022. It not only resolved historical issues but also became the first listed company to successfully complete restructuring after the implementation of the new "Nine Articles."

This 1000 million yuan investment in bacterial strains is just the tip of the iceberg for Red Sun's strategic transformation.After restructuring in 2022, Red Sun urgently needed a "second growth curve." In 2025, the company established its Central Research Institute and is advancing multiple biotechnology projects, including enzymatic K-amine production and polyoxin. In 4 of 2026, it launched Jiangsu Huazhou Bioengineering Co., Ltd., a newly formed subsidiary positioned as a key industrial platform for green agriculture and synthetic biology.

The emergence of the "Red Sun Subspecies" strain has helped Red Sun take a crucial step forward:The shift from a chemical pesticide-dominated product structure to one that integrates both chemicals and biologicals finally has a tangible lever.

[ Why Now? ]

The convergence of policy, technology, and market forces

Policy-Driven: National Mandate to Reduce Chemical Pesticide Use

Overuse of chemical pesticides has triggered a serious resistance crisis in China.Data shows that approximately 40% of pesticides in China pose high environmental and ecological risks, over 50% of traditional varieties face medium-to-high resistance risks, and dependence on chemical pesticides remains above 90%.Following the Ministry of Agriculture and Rural Affairs' release of the "Chemical Pesticide Reduction Action Plan for 2025," substituting chemical pesticides with biopesticides has become a prevailing trend.

Amid rising concerns over food safety and environmental pressure, insecticidal protein pesticides like HS18-1 offer a new approach. Estimates show thatThis biopesticide can replace 30%–50% of chemical pesticides.Saves 20-30 yuan per mu per season on pesticide and application costs.

Tech Breakthrough: The Fundamental Shift Driven by Synthetic Biology

Recent breakthroughs in synthetic biology are emerging at a rapid pace.Prof. Liu Liming's team from Jiangnan UniversitySet a world record for the highest productivity of PDA biosynthesis (130 g/L);Tianjin Institute of Industrial Biotechnology, Chinese Academy of SciencesThe High-Throughput Editing and Screening Platform Lab developed and optimized a broad-spectrum β-lactam biosensor, integrated it with droplet microfluidics, and applied it to high-throughput screening of Cephalosporin C-producing strains.Tianmu BiotechnologyLaunch the next-generation automated high-throughput strain breeding platform, integrating droplet microfluidics with automation. Leverage droplet microfluidics to reduce data dimensionality for million-level mutant libraries, and utilize an automated system to complete re-screening, validation, and preservation in a seamless workflow.

An undeniable trend is:AI and automation are reshaping the cost curve of strain development, transforming the industry's underlying dynamics.Traditional breeding methods are time-consuming, costly, and inefficient. By integrating synthetic biology with high-throughput screening, strain development has transitioned from a "craft-based era" to an "industrialized era." This significant boost in efficiency means more high-quality strains—like HS18-1—will enter the commercialization pipeline faster and at lower costs.

Market Size: Trillion-dollar growth opportunity

Market data and forecasts indicate that the global advanced strain engineering microbial platform market reached $1 billion in 2025 and is projected to hit $3 billion by 2032. The precision fermentation market is also experiencing rapid growth, with the application of mature chassis strains like yeast accelerating across food, feed, and pharmaceutical sectors.

Specifically for the biopesticide sectorThe global biopesticide market is projected to grow from $1 billion in 2023 to $3 billion in 2026, with a CAGR of 16.5%. This growth trajectory significantly outpaces the ~3% annual growth rate of traditional chemical pesticides.Reflects the urgent market demand for environmentally friendly plant protection solutions.

We can see thatStrain intellectual property is becoming the "hard currency" of the biomanufacturing era.These strains, developed with complete independent intellectual property rights, are becoming the core weapon for various industries to break through the bottleneck of "strain chokeholds."

Based on this,The 2026 BIO-TECH Manufacturing Industry Expo will be held grandly in Shanghai from 8/27-28.This exhibition is organized by Yimao Medical. Invited guests will be present on-site, including:2000+Attendee,150+ Speaker,50+Premium exhibitors, featuring "Exhibitions - Products - Conferences - PartnershipsFour core modules focused on "breakthroughs in fundamental research and cross-sector industrialization," establishing a benchmark event for the entire bio-manufacturing value chain.